The trend for an improved antitumor therapeutic effect existed even in these cells although to a lesser degree, thus supporting the conclusion that the immunogenic effect of the APR-246 is not necessarily dependent on p53 expression in the tumor. The gene discussed is TP53; the disease is neoplasm.